China Pharma Holdings (CPHI) Other Operating Expenses (2010 - 2026)
China Pharma Holdings (CPHI) posted Other Operating Expenses of $92717.0 for Q1 2026, up 12.64% on a QoQ basis from $82313.0 in Q4 2025, and up 8.08% year-over-year from $85788.0 in Q1 2025.
China Pharma Holdings (CPHI) Other Operating Expenses (2010 - 2026) Analysis & Trends
China Pharma Holdings' Other Operating Expenses history runs 17 years deep, the most recent figure standing at $92717.0 for Q1 2026.
- Quarterly Other Operating Expenses rose 8.08% year-over-year to $92717.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $381697.0 (down 25.77% YoY) and the FY2025 annual result came in at $374768.0, down 29.89% from the prior year.
- Other Operating Expenses was $92717.0 for Q1 2026 at China Pharma Holdings, up from $82313.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $354261.0 in Q4 2022 and bottomed at $82313.0 in Q4 2025.
- A 5-year average of $161324.5 and a median of $134396.0 in 2023 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses jumped 30.05% — and 2025, when it tumbled 53.11%.
- China Pharma Holdings' Other Operating Expenses stood at $354261.0 in 2022, then decreased by 24.35% to $267996.0 in 2023, then plunged by 34.5% to $175527.0 in 2024, then slumped by 53.11% to $82313.0 in 2025, then gained by 12.64% to $92717.0 in 2026.
- Business Quant data shows CPHI's Other Operating Expenses at $92717.0 in Q1 2026, $82313.0 in Q4 2025, and $103343.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92,717.00 |
| Dec 31, 2025 | 82,313.00 |
| Sep 30, 2025 | 103,343.00 |
| Jun 30, 2025 | 103,324.00 |
| Mar 31, 2025 | 85,788.00 |
| Dec 31, 2024 | 175,527.00 |
| Sep 30, 2024 | 132,947.00 |
| Jun 30, 2024 | 119,931.00 |
| Mar 31, 2024 | 106,121.00 |
| Dec 31, 2023 | 267,996.00 |
| Sep 30, 2023 | 188,312.00 |
| Jun 30, 2023 | 173,867.00 |
| Mar 31, 2023 | 134,396.00 |
| Dec 31, 2022 | 354,261.00 |
| Sep 30, 2022 | 185,540.00 |
| Jun 30, 2022 | 262,093.00 |
| Mar 31, 2022 | 174,040.00 |
| Dec 31, 2021 | 286,280.00 |
| Sep 30, 2021 | 142,664.00 |
| Jun 30, 2021 | 440,734.00 |